Erick Gamelin
Corporate Officer/Principal presso ACRIVON THERAPEUTICS, INC.
Patrimonio netto: 153 874 $ in data 30/04/2024
Profilo
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/02/2024 | 18 167 ( 0.06% ) | 153 874 $ | 30/04/2024 |
Posizioni attive di Erick Gamelin
| Società | Posizione | Inizio |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 03/01/2024 |
Precedenti posizioni note di Erick Gamelin
| Società | Posizione | Fine |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/10/2019 |
| MACROGENICS, INC. | Corporate Officer/Principal | 01/03/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| MACROGENICS, INC. | Health Technology |
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Erick Gamelin
